Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“)
Background: The multifactorial origin of cardiovascular diseases has led to polypharmacy in primary and secondary prophylaxis with evidence-based medications, such as statins, antihypertensive drugs and platelet aggregation inhibitors. The number of prescribed drugs correlates inversely to adherence...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch Englisch |
| Veröffentlicht: |
2018
|
| In: |
Herz
Year: 2017, Jahrgang: 43, Heft: 3, Pages: 246-257 |
| ISSN: | 0340-9937 |
| DOI: | 10.1007/s00059-017-4554-5 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00059-017-4554-5
|
| Verfasserangaben: | P. Bramlage, W. März, D. Westermann, B. Weisser, J.H. Wirtz, U. Zeymer, P. Baumgart, G. van Mark, U. Laufs, B.K. Krämer, T. Unger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 167016036X | ||
| 003 | DE-627 | ||
| 005 | 20230427055705.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190729r20182017xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00059-017-4554-5 |2 doi | |
| 035 | |a (DE-627)167016036X | ||
| 035 | |a (DE-599)KXP167016036X | ||
| 035 | |a (OCoLC)1341234715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bramlage, Peter |d 1969- |e VerfasserIn |0 (DE-588)122465040 |0 (DE-627)08196014X |0 (DE-576)256677980 |4 aut | |
| 245 | 1 | 0 | |a Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“) |c P. Bramlage, W. März, D. Westermann, B. Weisser, J.H. Wirtz, U. Zeymer, P. Baumgart, G. van Mark, U. Laufs, B.K. Krämer, T. Unger |
| 264 | 1 | |c 2018 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online publiziert: 24. März 2017 | ||
| 500 | |a Gesehen am 29.07.2019 | ||
| 520 | |a Background: The multifactorial origin of cardiovascular diseases has led to polypharmacy in primary and secondary prophylaxis with evidence-based medications, such as statins, antihypertensive drugs and platelet aggregation inhibitors. The number of prescribed drugs correlates inversely to adherence and can lead to treatment failure. Fixed-dose combination drugs (polypills) could increase the medication adherence of patients, reduce risks and prevent cardiovascular events. Methods: This review is based on publications that were retrieved from Medline (via PubMed) and The Cochrane Library. The clinical database ClinicalTrials.gov. was also considered. Results: In the studies on primary prevention conducted to date, fixed-dose combinations showed a superior control of risk factors, e.g. hypertension and low-density lipoprotein (LDL) cholesterol compared to placebo and at least non-inferiority compared to usual care. In secondary prevention, the effect of the polypill is mostly on the reduction of blood pressure and LDL cholesterol in non-adherent patients; however, evidence that fixed-drug combinations reduce cardiovascular morbidity and mortality compared to standard therapy is lacking. Conclusion: The polypill can be considered as an alternative to polypharmacy after a risk-benefit assessment, especially in non-adherent patients. Ongoing studies are investigating the effect of the polypill on cardiovascular events. Current polypills are limited by the lack of sufficient dosages of the individual components to avoid overtreatment and undertreatment at the individual treatment level. | ||
| 534 | |c 2017 | ||
| 546 | |a Mit englischer Zusammenfassung | ||
| 650 | 4 | |a Cardiovascular prevention | |
| 650 | 4 | |a Kardiovaskuläre Prävention | |
| 650 | 4 | |a LDL cholesterol | |
| 650 | 4 | |a LDL-Cholesterin | |
| 650 | 4 | |a Platelet aggregation inhibitors | |
| 650 | 4 | |a Polypill | |
| 650 | 4 | |a Systolic blood pressure | |
| 650 | 4 | |a Systolischer Blutdruck | |
| 650 | 4 | |a Thrombozytenhemmer | |
| 700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
| 700 | 1 | |a Krämer, Bernhard |d 1957- |e VerfasserIn |0 (DE-588)14017589X |0 (DE-627)70358927X |0 (DE-576)314926852 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Herz |d Berlin : Springer Medizin Verlag GmbH, 1976 |g 43(2018), 3, Seite 246-257 |w (DE-627)129098086 |w (DE-600)8262-4 |w (DE-576)014434784 |x 0340-9937 |7 nnas |a Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“) |
| 773 | 1 | 8 | |g volume:43 |g year:2018 |g number:3 |g pages:246-257 |g extent:12 |a Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“) |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00059-017-4554-5 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190729 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 14017589X |a Krämer, Bernhard |m 14017589X:Krämer, Bernhard |d 60000 |d 61400 |e 60000PK14017589X |e 61400PK14017589X |k 0/60000/ |k 1/60000/61400/ |p 10 | ||
| 998 | |g 1027603599 |a März, Winfried |m 1027603599:März, Winfried |d 60000 |d 61400 |e 60000PM1027603599 |e 61400PM1027603599 |k 0/60000/ |k 1/60000/61400/ |p 2 | ||
| 999 | |a KXP-PPN167016036X |e 3499591596 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Online publiziert: 24. März 2017","Gesehen am 29.07.2019"],"name":{"displayForm":["P. Bramlage, W. März, D. Westermann, B. Weisser, J.H. Wirtz, U. Zeymer, P. Baumgart, G. van Mark, U. Laufs, B.K. Krämer, T. Unger"]},"recId":"167016036X","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"language":["ger","eng"],"person":[{"role":"aut","display":"Bramlage, Peter","given":"Peter","family":"Bramlage"},{"given":"Winfried","family":"März","role":"aut","display":"März, Winfried"},{"family":"Krämer","given":"Bernhard","display":"Krämer, Bernhard","role":"aut"}],"relHost":[{"titleAlt":[{"title":"Cardiovascular diseases"},{"title":"Herz / Suppl."},{"title":"Herz / Sonderh."},{"title":"Herz / Spezial"},{"title":"Mitteilungen des BNK"},{"title":"Pharmawissen aktuell"},{"title":"kardiovasculäre Erkrankungen"}],"recId":"129098086","origin":[{"publisher":"Springer Medizin Verlag GmbH ; Urban & Schwarzenberg ; Urban & Vogel ; Springer Medizin","dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisherPlace":"Berlin ; München ; München ; München"}],"part":{"volume":"43","year":"2018","extent":"12","issue":"3","pages":"246-257","text":"43(2018), 3, Seite 246-257"},"pubHistory":["1.1976 -"],"type":{"bibl":"periodical"},"id":{"issn":["0340-9937"],"zdb":["8262-4"],"eki":["129098086"]},"disp":"Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“)Herz","note":["Ungezählte Beil.: Suppl.; Sonderh.; Spezial; Mitteilungen des BNK; ab 2014: Pharmawissen aktuell","Beteil. Körp. anfangs: Deutsches Herzzentrum München"],"corporate":[{"role":"isb","display":"Bundesverband Niedergelassener Kardiologen"},{"display":"Deutsches Herzzentrum München des Freistaates Bayern","role":"isb"}],"language":["ger"],"title":[{"title_sort":"Herz","title":"Herz","subtitle":"cardiovascular diseases ; Organ des Bundesverbandes Niedergelassener Kardiologen (BNK)"}],"physDesc":[{"noteFormat":"28 cm"}]}],"title":[{"title":"Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“)","title_sort":"Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“)"}],"id":{"doi":["10.1007/s00059-017-4554-5"],"eki":["167016036X"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a BRAMLAGEPEMANAGEMENT2018 | ||